GEODE CAPITAL MANAGEMENT, LLC - AMRYT PHARMA PLC ownership

AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 34 filers reported holding AMRYT PHARMA PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of AMRYT PHARMA PLC
ValueSharesWeighting
Q1 2023$467,931
+199870.5%
32,0940.0%0.00%
Q4 2022$234
-99.9%
32,0940.0%0.00%
Q3 2022$222,000
+6.7%
32,094
+7.4%
0.00%
Q2 2022$208,000
-15.4%
29,8790.0%0.00%
Q1 2022$246,000
-24.3%
29,879
-0.8%
0.00%
Q4 2021$325,000
-10.7%
30,128
-0.2%
0.00%
Q3 2021$364,000
+200.8%
30,181
+200.5%
0.00%
Q2 2021$121,00010,0420.00%
Other shareholders
AMRYT PHARMA PLC shareholders Q2 2021
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 8,857,268$64,658,05627.18%
Stonepine Capital Management, LLC 6,333,239$46,232,64519.45%
MPM ASSET MANAGEMENT LLC 2,668,843$19,482,5548.15%
Aquilo Capital Management, LLC 2,098,993$15,322,6495.76%
New Leaf Venture Partners, L.L.C. 449,737$3,283,0802.38%
Global Frontier Investments LLC 505,000$3,6871.62%
Telemetry Investments, L.L.C. 130,262$9511.50%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 6,333,552$46,2351.27%
Rubric Capital Management LP 3,600,000$26,280,0001.15%
Clearline Capital LP 631,942$4,613,1760.82%
View complete list of AMRYT PHARMA PLC shareholders